echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > JAMA Netw Open: Is there any abuse of opioid analgesics in patients with chronic non-cancerous pain (CNCP)?

    JAMA Netw Open: Is there any abuse of opioid analgesics in patients with chronic non-cancerous pain (CNCP)?

    • Last Update: 2021-04-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The increased long-term use of opioids in patients with chronic non-cancerous pain (CNCP) may raise concerns about opioid-related behaviors.


    These actions may include: non-medical use of opioids (including tampering with drugs), transfer of drugs to others, and the development of opioid dependence.


    Pixabay.


    Some researchers have used data from the pain and opioid treatment cohort (POINT cohort) to study this problem.


    Some researchers have used data from the pain and opioid treatment cohort (POINT cohort) to study this problem.


    This 5-year prospective cohort study included 1,514 adults who were treated with opioids prescribed by CNCP.


    This 5-year prospective cohort study included 1,514 adults who were treated with opioids prescribed by CNCP.


    Among the 1514 participants, 672 (44.


    The distribution of the number of interviews for a series of opioid use indicators and non-medical use indicators was observed in the point cohort (estimated data)

    The distribution of the number of interviews (estimated data) for a series of opioid use indicators and non-medical use indicators was observed in the spot cohort.


    The study examined the prevalence, incidence, stopping and duration of four opioid use behaviors, as well as three non-medical use and harm indicators.


    This finding challenges the prevailing view that the risk of opioid-related behaviors is static-risk assessment at the beginning of opioid treatment can predict which patients will develop opioid use disorder, thereby providing ongoing Provide information on the management plan.


    ,,,CNCP,。,。,。,,,CNCP,。,。,。,,,CNCP,。,。,。,,,CNCP,。,。,。CNCP,。,。,。CNCP,。,。,。

    :Degenhardt L, Hungerford P, Nielsen S, et al.


    :Degenhardt L, Hungerford P, Nielsen S, et al.
    Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults With Chronic Noncancer Pain, 2012-2018.
     JAMA Netw Open.
     2021;4(4):e213059.
    com/journals/jamanetworkopen/fullarticle/2778344" target="_blank" rel="noopener"> doi:10.
    1001/jamanetworkopen.
    2021.
    3059:Degenhardt L, Hungerford P, Nielsen S, et al.
    Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults With Chronic Noncancer Pain, 2012-2018.
     JAMA Netw Open.
     2021;4(4):e213059.
    com/journals/jamanetworkopen/fullarticle/2778344" target="_blank" rel="noopener"> doi:10.
    1001/jamanetworkopen.
    2021.
    3059:Degenhardt L, Hungerford P, Nielsen S, et al.
    Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults With Chronic Noncancer Pain, 2012-2018.
     JAMA Netw Open.
     2021;4(4):e213059.
    com/journals/jamanetworkopen/fullarticle/2778344" target="_blank" rel="noopener"> doi:10.
    1001/jamanetworkopen.
    2021.
    3059Degenhardt L, Hungerford P, Nielsen S, et al.
    Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults With Chronic Noncancer Pain, 2012-2018.
     JAMA Netw Open.
     2021;4(4):e213059.
    com/journals/jamanetworkopen/fullarticle/2778344" target="_blank" rel="noopener"> doi:10.
    1001/jamanetworkopen.
    2021.
    3059com/journals/jamanetworkopen/fullarticle/2778344" target="_blank" rel="noopener"> doi:10.
    1001/jamanetworkopen.
    2021.
    3059

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.